Arcus Biosciences, Inc. (RCUS) Social Stream



Arcus Biosciences, Inc. (RCUS): $24.41

-0.01 (-0.04%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RCUS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Arcus Biosciences Inc (RCUS) Price Targets From Analysts

Use the tables below to see what analysts covering Arcus Biosciences Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $70 $50 $59.833 $33.4 79.14%
2021-11-17 8 $70 $48 $58.142 $33.4 74.08%
2021-11-18 8 $100 $48 $62.714 $33.4 87.77%
2021-11-22 9 $100 $48 $64.857 $33.4 94.18%
2022-02-24 7 $100.001 $53 $67 $33.4 100.6%
2022-03-29 7 $100.001 $53 $68 $33.4 103.59%

The Trend in the Analyst Price Target


RCUS's average price target has moved up $8.17 over the prior 140 days.

Over the past 140 days, RCUS's average upside potential has been 54.81%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-09 8 70 48 58.142 38.90 49.47%
2021-11-18 8 100 48 62.714 43.54 44.04%
2021-11-22 7 100 53 67.000 48.09 39.32%
2021-11-22 9 100 48 64.857 48.09 34.87%
2021-11-22 9 100 50 64.875 48.09 34.9%

RCUS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


Over the past 28 days, RCUS's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • RCUS has a lower variance in analysts' estimates than -581.42% of all US stocks.
  • In the context of all US stocks, Arcus Biosciences Inc's upside potential (average analyst target price relative to current price) is greater than 684.48% of them.
  • RCUS has a higher average analyst price target than 691.37% of Pharmaceutical Products stocks.
  • Arcus Biosciences Inc's number of analysts covering the stock is higher than 616.26% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, RCKT, QURE, and PTGX are the three stocks most similar to Arcus Biosciences Inc regarding the price target and analyst recommendation information presented here.

Is RCUS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3983 seconds.